The Patient Investing Blueprint

The maiden episode of the The Patient Investing Blueprint is about a topic near and dear to the hearts of Blue Stamp investors - invoice payments. Many small businesses in Australia (and globally) suffer from poor cash flow as a result of offering lengthy payment terms on their invoices which often are paid late, and sometimes, not at all! Marmalade is a core holding in the Blue Stamp Trust, the only fund managed by Blue Stamp Company, and an invoice payments company started to solve this massive problem for the many SMBs that haven't traditionally been able to access a cash flow solution that didn't add risk to their business. In this episode, Blue Stamp's Portfolio Manager, Brock McCamley, sits down with Marmalade co-founder Luke Trickett to chat about Marmalade, the problems it solves in the market, how it's different to existing solutions out there, and the secret sauce (better put, "sauces") that will insulate it from competitive threats. The Owner's Manual that was spoken about at 46:40 can be found here. For more information on Marmalade, please visit the website https://www.withmarmalade.com.au/ For more information about Blue Stamp Company and the Fund it manages, please visit https://www.bluestampcompany.com/ Hope you enjoy! BM.